Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Coherus BioSciences, Inc. | chrs-ex321_7.htm |
| EX-31.2 - EX-31.2 - Coherus BioSciences, Inc. | chrs-ex312_9.htm |
| EX-31.1 - EX-31.1 - Coherus BioSciences, Inc. | chrs-ex311_8.htm |
| 10-K - CHRS-10K-20161231 - Coherus BioSciences, Inc. | chrs-10k_20161231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement (Form S-3 No. 333-208625) of Coherus BioSciences, Inc.; Registration Statements (Form S-8 Nos. 333-200593, 333-203356 and 333-209936) pertaining to the BioGenerics, Inc. 2010 Equity Incentive Plan, as amended, the Coherus BioSciences, Inc. 2014 Equity Incentive Award Plan, and the Coherus BioSciences, Inc. 2014 Employee Stock Purchase Plan; and Registration Statement (Form S-8 No. 333-213077) pertaining to the 2016 Employment Commencement Incentive Plan of Coherus BioSciences, Inc. of our reports dated March 13, 2017, with respect to the consolidated financial statements of Coherus BioSciences, Inc., and the effectiveness of internal control over financial reporting of Coherus BioSciences, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2016.
/s/ERNST & YOUNG LLP
Redwood City, California
March 13, 2017